ConjuGon Raises $3.3 Million

ConjuGon Inc., a < ?xml:namespace prefix = st1 ns = "urn:schemas-microsoft-com:office:smarttags" />Madison, Wis.-based drug company focused on the treatment of antibiotic resistant bacterial infections, has raised $3.3 million in VC funding. Rosetta Partners led the deal, and was joined by returning angel backer Wisconsin Investment Partners. www.conjugon.com < ?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />